[HIGHLIGHTS] Pulmonary fibrosis, a new drug developed thanks to AI - Medicine

Pulmonary fibrosis, a new drug developed thanks to AI - Medicine. It works by inhibiting the Tnik gene (ANSA) New promising discovery to fight idiopathic pulmonary fibrosis (IPF), a serious and often lethal lung disease.

In just 18 months, thanks to Artificial Intelligence (AI), a new therapeutic target was identified, an effective drug was developed and its safety verified. The work of "biogerontology" and its "InSilicoMeds" team was published in nature biotechnology.